Private Practice Rheumatologist, Patras, Greece
Volume 27, Issue 3, September 2016
Sign in to download the Issue in PDF format.
1159754943
Mediterr J Rheumatol 2016;27(3):111-4
Article Links
Bilateral pitting oedema in an elderly patient: a typical case of RS3PE syndrome and literature review
References
- McCarthy D J, O’Duffy D J, Pearson L, et al. Remitting Seronegative Symmetrical Synovitis with Pitting oedema. RS3PE Syndrome. JAMA 1985;254:2763-7.
- Karmacharya P, Donato A A, Aryal M R, Ghimire S, Pathak P, Shah K, et al. RS3PE revisited. A systematic review and meta-analysis of 331 cases. Clin Exp Rheum 2016;34:404-15.
- Salam A, Rafik H, Sheeran T: Acute onset polyarthritis in older people. Is it RS3PE syndrome? Cases Journal 2008;1:132
- Olive A, del Bianco J, Pons M, Vaquero M, Tena X. The clinical spectrum of remitting seronegative symmetrical synovitis with pitting oedema. The Catalan Group for the Study of RS3PE. J Rheumatology 1997;24:333-6.
- Dudler J, Gerster J C, So A. Polyarthritis and pitting oedema. Ann Rheum Dis 1999;58:142-7.
- Shaeverbeke T, Vernhes J P, Bannwarth B, Dehais J. Is remitting seronegative symmetrical synovitis with pitting oedema (RS3PE syndrome) associated with HLA-A2? Br J Rheumatology 1995;34:889-890.
- Arima K, Origuchi T, Tamai M, Iwanaga N, Izumi Y, Huang M, et al. RS3PE syndrome presenting as vascular endothelial growth factor associated disorder. Ann Rheum Dis 2005;64:1653-5.
- Roblot P, Zaim A, Azais I, et al. RS3PE: A clinical diagnosis, a prognosis more simple than its name. Rev Med Interne 1998;19:542-7.
- Russell E B, Hunter J B, L Pearson, et al. Remitting, seronegative, symmetrical synovitis with pitting oedema- 13 additional cases. J Rheumatol 1990;17:633-9.
- Healey L A. RS3PE syndrome. J Rheumatol 1990;17:414.
- Kimura M, Tokuda Y, Oshiawa H, et al. Clinical characteristics of patients with remitting seronegative symmetrical synovitis with pitting oedema compared to patients with pure polymyalgia rheumatica. J Rheumatol 2012;39:148-53.
- Dasgupta B, Cimmino M A, Cremers H M, Schmidt W A, Schirmer M, Salvarani C, et al. 2012 provision classification criteria for polymyalgia rheumatica: A European League Against Rheumatology/American College of Rheumatology collaborative initiative. Arthritis Rheum 2012 Apr;64:943-54.
- Agarwal V, Dabra A K, Kaur R, et al. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: Ultrasonography as a diagnostic tool. Clin Rheumatol 2005;24:476-9.
- Cantini F, Salvarani C, Olivieri I. Paraneoplastic remitting seronegative symmetrical synovitis. Clin Exp Rheumatol 1999;17:741-4.
- Sayarlioglu M. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome and malignancy. Eur J Ger Med 2004;1:3-5.
- Smitten A L, Simon T A, Hochberg M C, et al. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthr Res Ther 2008;10:R45.
- Manger B, Schett G. Araneoplastic syndromes in Rheumatology. Nature Rev Rheumatology 2014;10:662-70.
- Shaeverbeke T, Fatout E, Marce S, Vernhes J P, Halle O, Antoine J F, et al. Remitting seronegative symmetrical synovitis with pitting oedema: disease or syndrome? Ann Rheum Dis 1995;54:681-4.
- Paira S, Graf C, Roverano S, et al. Remitting seronegative symmetrical synovitis with pitting oedema: A study of 12 cases. Clin Rheumatol 2002;21:146-9.
- Calis M, Cuce I, Akgul O, Cuce E G, Candan V. The treatment approach for the remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome. Doi:100136/annrheumdis-2015-eular.3312.
- Izumi K, Kuda H, Ushikubo M, Kuwana M, Takeuchi T, Oshima H. Tocilizumab is effective against polymyalgia rheumatica. Experience in 13 intractable cases. RMD Open 2015;1:e000162.
- Furst D, Fleishman R, Kalden J, Kavanaugh A, Sieper J, Mease P, et al. Documentation of off-label use of biologics in Rheumatoid Arthritis. Ann Rheum Dis 2013;72:ii35-ii51.
- Mehta P, Chong S, Carulli M, Haskaard D. Steroid-resistant remitting seronegative symmetrical synovitis with pitting oedema associated with gout treated with etanercept (letter). Rheumatology 2014;53:1908-10.
- Guma M, Casado E, Tena X. RS3PE: Six years later. Ann Rheum Dis 1999;58:722-3.